We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novo Nordisk launched half-priced generic versions of NovoLog and NovoLog Mix in the U.S. Tuesday, aiming to provide cheaper insulin products. Read More
The FDA issued a warning letter to LNK International for failing to fully investigate contaminated lots of antihistamines it released to the market. Read More
The FDA is taking issue with a new study that says the agency can’t tell if its risk evaluation and mitigation strategy (REMS) program for extended-release and long-acting opioids is effective. Read More
Merck is expecting a decision from the FDA in January on a supplemental NDA for its blockbuster oncology drug Keytruda (pembrolizumab) for treatment of high-risk, non-muscle invasive bladder cancer. Read More
Lawmakers failed to enact drug pricing legislation in 2019 but they will be under intense pressure to try again in the new year as presidential campaigns begin to pick up steam. Read More